已发表论文

无创技术用于早期检测的口腔鳞状细胞癌:一项叙述性综述

 

Authors Yang J, Yuan Z , Mei S, Liu H, Xiang Q, Song E

Received 22 September 2025

Accepted for publication 24 January 2026

Published 4 February 2026 Volume 2026:18 569352

DOI https://doi.org/10.2147/CMAR.S569352

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 6

Editor who approved publication: Professor Kattesh Katti

Jingyi Yang,1,2,* Zineng Yuan,3,* Shasha Mei,2 Hanqing Liu,1 Qiong Xiang,2 Enfeng Song1 

1School of Chinese Medicine, Hubei University of Chinese Medicine, Wuhan City, Hubei Province, People’s Republic of China; 2Department of Chinese Medicine, Renmin Hospital of Wuhan University, Wuhan City, Hubei Province, People’s Republic of China; 3Shanghai Medical College, Fudan University, Shanghai City, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Enfeng Song, School of Chinese Medicine, Hubei University of Chinese Medicine, No. 188, Tanhualin, Wuchang District, Wuhan City, Hubei Province, 430000, People’s Republic of China, Email songef@126.com

Abstract: Oral squamous cell carcinoma (OSCC) is the most common malignant tumor of the oral cavity, accounting for the majority of oral cancers, and early detection is crucial for improving patient survival rates and prognosis. Traditional diagnostic methods have limitations, including invasiveness and diagnostic delays, and are insufficient for early detection and distinguishing between similar diseases. In recent years, with the rapid advancement of molecular biology and biotechnology, a variety of emerging non-invasive diagnostic approaches have provided new strategies for early screening and precise diagnosis of OSCC. This review summarizes the cutting-edge technologies in OSCC diagnosis in recent years, including biomarker-based detection (such as microRNA, circRNA, gene methylation, and salivary proteomics), oral microbiome analysis, optical imaging technologies combined with artificial intelligence, and more. These emerging methods not only offer non-invasive or minimally invasive advantages but also enable the detection of potential molecular changes in the early stages of the disease, allowing for early intervention. Despite the challenges in standardization, sensitivity, and specificity optimization that these new technologies face in clinical applications, they undoubtedly offer vast prospects for early detection and personalized treatment of OSCC. This review aims to achieve the following objectives: First, to systematically evaluate the latest research evidence on various emerging non-invasive diagnostic technologies; second, to comprehensively compare their advantages and limitations relative to traditional methods; and finally, to attempt constructing a clinical translation assessment framework for early-stage multimodal diagnostic technologies in OSCC, thereby guiding future translational strategies.

Keywords: OSCC, emerging diagnostic approaches, biomarkers, oral microbiome, optical imaging